Cell Therapy in solid tumours

Adoptive T-Cell Therapy for Solid Tumors Chimeric antigen receptor (CAR) T-cell therapy is an innovative form of immunotherapy wherein autologous T cells are genetically modified to express chimeric receptors encoding an antigen-explicit single-chain variable piece and different costimulatory atoms. Chimeric antigen receptor T-cell therapy is an innovative form of immunotherapy wherein autologous T cells are genetically modified to express chimeric receptors encoding an antigen-specific single-chain variable fragment and various costimulatory molecules. Upon organization, these adjusted T cells traffic to, and perceive, malignant growth cells in a HLA-autonomous way.

  • Adoptive T-cell Therapy
  • Solid Tumor Cell Therapy
  • Tumor cell Therapy

Related Conference of Cell Therapy in solid tumours

September 28-29, 2026

36th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
October 05-06, 2026

22nd International Conference on Cancer Research

Madrid, Spain
November 19-20, 2026

44th World Cancer Conference

Dubai, UAE
November 23-24, 2026

8th International Conference on Women Oncology

Miami, USA
November 23-24, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
November 24-25, 2026

6th International Conference on Oncology and Cancer

Paris, France
December 03-04, 2026

10th Global Meeting on Oncology and Radiology

Madrid, Spain
December 08-09, 2026

14th Euro Breast Cancer and Therapeutics

Paris, France
December 08-09, 2026

27th World Congress on Cancer Summit

Paris, France
February 15-16, 2027

5th World Congress on Oral Cancer

Singapore City, Singapore
April 15-16, 2027

12th World Conference on Breast and Cervical Cancer

Amsterdam, Netherlands

Cell Therapy in solid tumours Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in